Harnessing mRNA-encoded Cytokines as Immune Therapeutics for a Focused Immune Response

Time: 4:10 pm
day: Conference Day One


  • Engineered cytokines encoded by nucleoside modified mRNA and delivered in LNPs enables tailored and focused immune therapeutics
  • Multiplexing a myriad of cytokines by the mRNA/LNP platform allows next-generation broad immunomodulation for clinical benefit
  • Providing examples of harnessing mRNA technology for manipulating the immune response via cytokines for autoimmune and inflammatory disease